Skip to main content

Table 3 HDL of various groups of rats in 60 days study trial

From: Phytochemical composition, antilipidemic and antihypercholestrolemic perspectives of Bael leaf extracts

Rat Groups

HDL (mg/dL)

 

Day-0

Day-30

Day-60

Control

 G0

49.53 ± 0.36Bb

52.89 ± 0.44Aba

51.05 ± 0.24Ba

 G1

50.60 ± 0.35Aa

51.91 ± 0.25Aa

53.07 ± 0.31Aab

 G2

49.07 ± 0.67Ba

51.71 ± 0.89Ba

54.48 ± 0.79Aa

Net Changes in Control Group

 G1 - G0

1.07 ± 0.01f

0.98 ± 0.19f

2.02 ± 0.07b

 G2 - G0

0.46 ± 0.31g

1.18 ± 0.45e

3.43 ± 0.55a

 G2 - G1

1.53 ± 0.32c

0.20 ± 0.64h

1.41 ± 0.48d

HPL Group

 Gh0

30.01 ± 0.27Aa

28.70 ± 0.84ABb

26.77 ± 0.27Cb

 Gh1

30.12 ± 0.31Ca

36.82 ± 0.98Ba

40.18 ± 0.64Ba

 Gh2

30.34 ± 0.76Ca

38.39 ± 0.63Ba

45.46 ± 0.90Aa

Net Changes in HPL Group

 Gh1 - Gh0

0.11 ± 0.04g

8.12 ± 0.14d

13.41 ± 0.37b

 Gh2 - Gh0

0.33 ± 0.49g

9.69 ± 0.21c

18.69 ± 0.63a

 Gh2 - Gh1

0.22 ± 0.45g

1.57 ± 0.35f

5.28 ± 0.26e

  1. Mean ± Standard Deviation; n = 10
  2. G0: Control Normal rat group. G1: Normal rat group fed on 125 mg
  3. bael leaf extract. G2: Normal rat group fed on 250 mg bael leaf extract
  4. Gh0: Control Hyperlipidemic rat group. Gh1: Hyperlipidemic rat group fed on 125 mg
  5. bael leaf extract. Gh2: Hyperlipidemic rat group fed on 250 mg bael leaf extract
  6. HPL: Hyperlipidemic group of rats
  7. Means showing different lower case letters (a, b, c, d, e, f, g) represent significant differences (p < 0.05) within control or HPL groups. Whereas, means showing different upper case letters (A, B, C) represent significant differences (p < 0.05) across day-0 through day-60